Evidence map›Paper›PMID 41196921›Full record

ArticlePLoS pathogens2025

Identification and characterization of a ubiquitin E3 RING ligase of the Chlamydia-like bacterium Simkania negevensis.

Eva-Maria Hörner, Vanessa Lachmayer, Thomas Hermanns, Adriana Moldovan, Kay Hofmann, Vera Kozjak-Pavlovic

Abstract read
In one paragraph

Article in PLoS pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Eva-Maria HörnerChair of Microbiology, Biocenter, Julius-Maximilian University Würzburg, Würzburg, Germany.
Vanessa LachmayerInstitute for Genetics, University of Cologne, Cologne, Germany.
Thomas HermannsInstitute for Genetics, University of Cologne, Cologne, Germany.
Adriana MoldovanChair of Microbiology, Biocenter, Julius-Maximilian University Würzburg, Würzburg, Germany.
Kay HofmannInstitute for Genetics, University of Cologne, Cologne, Germany.
Vera Kozjak-PavlovicChair of Microbiology, Biocenter, Julius-Maximilian University Würzburg, Würzburg, Germany.ORCID 0000-0001-9658-7018

Funding

Deutsche Forschungsgemeinschaft (DFG, German Research Society)
6 · The paper itself

Abstract

In the arms race between a pathogen and the host, the defense mechanisms of the host cell, including the ubiquitin system, are often counteracted by bacteria. Simkania negevensis (Sne), an obligate intracellular Chlamydia-like bacterium connected with respiratory diseases, possesses numerous deubiquitinases, but not much is known about its other ubiquitin-modifying enzymes. Sne infects a wide range of hosts, developing inside a tubular vacuole in close contact with the host endoplasmic reticulum (ER) and mitochondria. Our study describes an uncharacterized Sne ubiquitin E3 RING-ligase (SNE_A12920 or SneRING), which primarily generates K63- and K11-linked ubiquitin chains and preferentially interacts with UbcH5b and UBE2T E2 enzymes. SneRING is expressed upon infection of various human cell lines, as well as amoebae. We show that a portion of the expressed SneRING co-localizes with mitochondria and ER and that the SneRING interactome includes mitochondrial and ER proteins involved in organelle morphology and stress response. Our work offers an initial characterization of a bacterial RING ligase potentially involved in the host cell remodeling to accommodate the unique intracellular lifestyle of Sne.

Indexed as

Bacterial ProteinsChlamydialesUbiquitin-Protein LigasesChlamydiaEndoplasmic ReticulumHost-Pathogen InteractionsHumansMitochondriaBacterial ProteinsUbiquitin-Protein Ligases

Identifiers

PMID41196921
PMCPMC12591485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.